Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioGenex Laboratories has settled patent litigation with Ventana Medical Systems, with an agreement to cross license several of their patents.
Subscribe to our email newsletter
California-based BioGenex is licensed to utilize Ventana patented methods of bar-coding slides and reagents to control automated processing of samples, and Ventana is licensed to use BioGenex’s patented methods for antigen retrieval and de-paraffinization for preparation of samples. The companies further agreed to cooperate in the defense of the cross licensed patents and pursue third parties who infringe on them.
Krishan Kalra, chairman and CEO of BioGenex, said: “We are pleased to resolve the patent disputes with Ventana. This agreement also emphasizes the value of BioGenex patents on methods for preparation of tissue samples for laboratory tests and this cross license with Ventana will help us both ensure that our respective patents are widely used by the industry under license agreements.”